Evidence map›Paper›PMID 24493721›Full record

GuidelineJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Karen H Lu, Marie E Wood, Molly Daniels, Cathy Burke, James Ford, Noah D Kauff, Wendy Kohlmann, Noralane M Lindor, Therese M Mulvey, Linda Robinson and 8 more

Registry-linked trialAbstract readPractice Guideline
In one paragraph

Guideline in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06708429 (Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome), which is not on this map. Cited by 94 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06708429 recruitingnot on this mapstarted 2023, after this paper: background citation

Impact of Immune-surveillance on the Development of Colorectal Cancer in Patients With Lynch Syndrome

TypeobservationalSponsorSan Raffaele UniversityRan2023 to 2034Enrolled300ConditionsLynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, Lynch Syndrome I (Site-specific Colonic Cancer)ArmsLYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System)
3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Family history tools for primary care: A systematic review.The European journal of general practice · 2022
    Pooled it
  2. Guideline
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Use of Family Relationships in Commercial Claims Data to Characterize Clinical Events of Patients withAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Developments in Genetics: Better Management of Ovarian Cancer Patients.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Karen H LuKaren H. Lu, Molly Daniels, and Cathy Burke, MD Anderson Cancer Center, Houston; Linda Robinson, Simmons Comprehensive Cancer Center, Dallas, TX; Marie E. Wood, University of Vermont, Burlington, VT; James Ford, Stanford University Medical Center, Stanford, CA; Noah D. Kauff, Memorial Sloan-Kettering Cancer Center, New York, NY; Wendy Kohlmann, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Noralane M. Lindor, Mayo Clinic, Scottsdale, AZ; Therese M. Mulvey, Southcoast Centers for Cancer Care, Fall River; Sapna Syngal, Dana-Farber Cancer Institute, Brigham and Women's Hospital; Kevin S. Hughes, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Boston, MA; Wendy Rubinstein, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD; Elena M. Stoffel, University of Michigan, Ann Arbor, MI; Carrie Snyder, Creighton University, Omaha, NE; and Janette K. Merrill and Dana Swartzberg Wollins, American Society of Clinical Oncology, Alexandria, VA.
Marie E Wood
Molly Daniels
Cathy Burke
James Ford
Noah D Kauff
Wendy Kohlmann
Noralane M Lindor
Therese M Mulvey
Linda Robinson
Wendy S Rubinstein
Elena M Stoffel
Carrie Snyder
Sapna Syngal
Janette K Merrill
Dana Swartzberg Wollins
Kevin S Hughes
American Society of Clinical Oncology

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCERP50CA083639 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C · 1999 to 2015
$33.0M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA083639
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic CounselingGenetic Predisposition to DiseaseGenetic TestingHeredityHumansMedical History TakingMedical OncologyNeoplasmsPedigreePhenotypePractice Patterns, Physicians'Predictive Value of TestsPrognosisQuality Indicators, Health CareRisk AssessmentRisk Factors

Identifiers

PMID24493721
PMCPMC3940540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.